Evidence map›Paper›PMID 39935888›Full record

ReviewAlzheimer's & dementia (Amsterdam, Netherlands)

Natural language processing in Alzheimer's disease research: Systematic review of methods, data, and efficacy.

Arezo Shakeri, Mina Farmanbar

Abstract readReview
In one paragraph

Review in Alzheimer's & dementia (Amsterdam, Netherlands). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Arezo ShakeriDepartment of Electrical Engineering and Computer Science Faculty of Science and Technology University of Stavanger Stavanger Norway.ORCID https://orcid.org/0000-0003-3823-2619
Mina FarmanbarDepartment of Electrical Engineering and Computer Science Faculty of Science and Technology University of Stavanger Stavanger Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAlzheimer's disease (AD) prevalence is increasing, with no current cure. Natural language processing (NLP) offers the potential for non-invasive diagnostics, social burden assessment, and research advancements in AD.

methodA systematic review using Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines explored NLP applications in AD, focusing on dataset types, sources, research foci, methods, and effectiveness. Searches were conducted across six databases (ACM, Embase, IEEE, PubMed, Scopus, and Web of Science) from January 2020 to July 2024.

resultsOf 1740 records, 79 studies were selected. Frequently used datasets included speech and electronic health records (EHR), along with social media and scientific publications. Machine learning and neural networks were primarily applied to speech, EHR, and social media data, while rule-based methods were used to analyze literature datasets. DISCUSSION: NLP has proven effective in various aspects of AD research, including diagnosis, monitoring, social burden assessment, biomarker analysis, and research. However, there are opportunities for improvement in dataset diversity, model interpretability, multilingual capabilities, and addressing ethical concerns. Highlights: This review systematically analyzed 79 studies from six major databases, focusing on the advancements and applications of natural language processing (NLP) in Alzheimer's disease (AD) research.The study highlights the need for models focusing on remote monitoring of AD patients using speech analysis, offering a cost-effective alternative to traditional methods such as brain imaging and aiding clinicians in both prediagnosis and post-diagnosis periods.The use of pretrained multilingual models is recommended to improve AD detection across different languages by leveraging diverse speech features and utilizing publicly available datasets.

Indexed as

Alzheimer's diseasedementianatural language processingPRISMA guidelinessystematic review

Identifiers

PMID39935888
PMCPMC11812127

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.